GoHealth, Inc. (NASDAQ: GOCO) Q4 2020 earnings call dated Mar. 08, 2021
Corporate Participants:
Jay Koval — GoHealth, Inc.Vice President of Investor Relations
Clint P. Jones — Co-Founder and Chief Executive Officer
Travis Matthiesen — Chief Financial Officer
Shane Cruz — Chief Operating Officer
Analysts:
Jailendra Singh — Credit Suisse — Analyst
Frank Morgan — RBC — Analyst
Mike Cherny — Bank of America — Analyst
Tobey Sommer — Truist Securities — Analyst
Yaron Kinar — Goldman Sachs — Analyst
Jonathan Yong — Barclays — Analyst
Nathan Abraham — Morgan Stanley — Analyst
Elizabeth Anderson — Evercore ISI — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) stock research summary | Q3 2021
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key
Listen On
